Tsuji Kunikazu
Department of Cartilage Regeneration, Tokyo Medical and Dental University, Japan.
Clin Calcium. 2018;28(6):817-824.
Osteoarthritis(OA)is a group of diseases and mechanical abnormalities involving degradation of articular cartilage and subchondral bone. The major complaint of OA patients is persistent knee pain, which significantly decreases patients' activities of daily living. Therefore, most of the current treatment strategies for OA are based on symptom management by anti-inflammatory analgesics and improving joint mobility and flexibility by programed exercise and weight control. Recent progress in the field of cartilage metabolism led to develop new drug targets those play roles in structural disease modification in osteoarthritic joints.
骨关节炎(OA)是一组涉及关节软骨和软骨下骨降解的疾病及机械性异常。OA患者的主要症状是持续性膝关节疼痛,这显著降低了患者的日常生活活动能力。因此,目前大多数针对OA的治疗策略都是基于通过抗炎镇痛药进行症状管理,以及通过有计划的运动和体重控制来改善关节活动度和灵活性。软骨代谢领域的最新进展促使人们开发出新的药物靶点,这些靶点在骨关节炎关节的结构性疾病改善中发挥作用。